v3.23.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (7,121,914) $ (18,729,609)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain on sale of asset (4,500)
Accrued interest 9,146 57,536
Change in fair value of liability classified warrants (279,873) (5,626,130)
Loss on issuance of convertible notes 3,609,944
Change in fair value of convertible notes (146,479) (6,169,929)
Stock-based compensation 250,224 855,160
Issuance of liability classified warrants 3,737,371
Lease cost (135) (63)
Issuance costs paid to close convertible notes 946,085
Loss on debt conversions 4,000,155
Changes in operating assets and liabilities:    
Unbilled receivable 169,083 300,908
Prepaid expenses and other assets 1,235,252 475,499
Accounts payable (2,027,375) 984,410
Accrued expenses and other liabilities (1,066,036) 971,344
Net cash used in operating activities (8,978,107) (14,591,819)
Cash flows from investing activities:    
Proceeds from sale of asset 4,500
Net cash provided by investing activities 4,500
Cash flows from financing activities:    
Proceeds public offerings, net 9,050,004
Proceeds from issuance of convertible notes, net 7,533,915
Transaction costs associated with public offerings (447,879)
Repayments of convertible notes (1,000,208) (265,812)
Repayment of financed insurance premiums (307,131) (442,439)
Net cash provided by financing activities 7,294,786 6,825,664
Decrease in cash and cash equivalents (1,683,321) (7,761,655)
Cash and cash equivalents beginning of period 3,147,702 12,264,736
Cash and cash equivalents end of period 1,464,381 4,503,081
Supplemental cash flow information:    
Income tax payments 1,600
Supplemental disclosure of non-cash investing and financing activities:    
Stock-based compensation 1,742,478
Conversions of convertible notes into common stock 3,056,892 13,879,535
Payable to related parties 800,000
Proceeds from financed insurance premiums, net 445,737 399,949
Settlement of commitment fee in shares 400,000
Deemed dividend related to warrants down round provision $ 12,038 $ 881,598

Source

PDF HTML
ZIP XLS XBRL